Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project.
Sargas C, Ayala R, Chillón MC, Larráyoz MJ, Carrillo-Cruz E, Bilbao C, Yébenes-Ramírez M, Llop M, Rapado I, García-Sanz R, Vázquez I, Soria E, Florido-Ortega Y, Janusz K, Botella C, Serrano J, Martínez-Cuadrón D, Bergua J, Amigo ML, Martínez-Sánchez P, Tormo M, Bernal T, Herrera-Puente P, García R, Algarra L, Sayas MJ, Costilla-Barriga L, Pérez-Santolalla E, Marchante I, Lavilla-Rubira E, Noriega V, Alonso-Domínguez JM, Sanz MÁ, Sánchez-Garcia J, Gómez-Casares MT, Pérez-Simón JA, Calasanz MJ, González-Díaz M, Martínez-López J, Barragán E, Montesinos P. Sargas C, et al. Among authors: calasanz mj. Haematologica. 2021 Dec 1;106(12):3079-3089. doi: 10.3324/haematol.2020.263806. Haematologica. 2021. PMID: 33179471 Free PMC article.
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.
Sanz MA, Martín G, González M, León A, Rayón C, Rivas C, Colomer D, Amutio E, Capote FJ, Milone GA, De La Serna J, Román J, Barragán E, Bergua J, Escoda L, Parody R, Negri S, Calasanz MJ, Bolufer P; Programa de Estudio y Traitmiento de las Hemopatías Malignas. Sanz MA, et al. Among authors: calasanz mj. Blood. 2004 Feb 15;103(4):1237-43. doi: 10.1182/blood-2003-07-2462. Epub 2003 Oct 23. Blood. 2004. PMID: 14576047 Free article. Clinical Trial.
Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.
Lahortiga I, Agirre X, Belloni E, Vázquez I, Larrayoz MJ, Gasparini P, Lo Coco F, Pelicci PG, Calasanz MJ, Odero MD. Lahortiga I, et al. Among authors: calasanz mj. Oncogene. 2004 Jan 8;23(1):311-6. doi: 10.1038/sj.onc.1206923. Oncogene. 2004. PMID: 14712237 Free article.
Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements.
Lahortiga I, Vázquez I, Agirre X, Larrayoz MJ, Vizmanos JL, Gozzetti A, Calasanz MJ, Odero MD. Lahortiga I, et al. Among authors: calasanz mj. Genes Chromosomes Cancer. 2004 Jul;40(3):179-89. doi: 10.1002/gcc.20033. Genes Chromosomes Cancer. 2004. PMID: 15138998 Free article.
Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion.
Vizmanos JL, Larráyoz MJ, Vázquez I, Odero MD, Hernández R, Lahortiga I, Novo FJ, Ardanaz MT, Calasanz MJ. Vizmanos JL, et al. Among authors: calasanz mj. Cancer Genet Cytogenet. 2004 Jul 15;152(2):177-8. doi: 10.1016/j.cancergencyto.2003.12.002. Cancer Genet Cytogenet. 2004. PMID: 15262444 Free article. No abstract available.
238 results